课题基金 / 基金详情

Clonal tracking and molecular characterization of hematopoiesis under stress

Clonal tracking and molecular characterization of hematopoiesis under stress
应激条件下造血的克隆追踪和分子特征
批准号:
9209617
负责人:
David T Scadden
金额:
$39.88万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

David T Scadden的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
RESEARCH SUMMARY Hematopoiesis is now recognized as the integrated activity of multiple, largely progenitor clones with heterogeneous behavior. Clonal complexity is thought to diminish with age and human studies suggest that oligoclonal hematopoiesis with disease associated mutations is common. The presence of such clones incurs a substantial risk of hematologic neoplasia and all cause mortality. The overall goal of this proposal is to understand the molecular drivers of clonal behavior under stress conditions and to test whether modifying those drivers is capable of changing the relative competitive balance of normal and abnormal, risk bearing clones in animal models. We will use techniques of fluouresence clonal tracking in the mouse developed by us and compare these with retrotransposon clonal marking techniques in the mouse of Carmago and fluorescence clonal tracking techniques in the zebrafish developed by Zon. Further, we will characterize genetic characteristics of clones at single cell resolution using techniques of Tenen and define ncRNA candidate molecular drivers with Tenen. Finally, we will target epigenetic modifiers defined by Orkin, Tenen and Zon to test the impact on clonal competition between normal and mutant clones in vivo. Combined these complementary and collaborative approaches will point to methods for altering competitive relationships in hematopoiesis in favor of normal cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional consequences of stem and progenitor cell heterogeneity
  • 批准号:
    10413502
  • 项目类别:
  • 资助金额:
    $5.04万
  • 财政年份:
    2020
  • 负责人:
    David T Scadden
  • 依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
  • 批准号:
    10409803
  • 项目类别:
  • 资助金额:
    $55.27万
  • 财政年份:
    2020
  • 负责人:
    David T Scadden
  • 依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
  • 批准号:
    10163909
  • 项目类别:
  • 资助金额:
    $49.97万
  • 财政年份:
    2020
  • 负责人:
    David T Scadden
  • 依托单位:
Functional consequences of stem and progenitor cell heterogeneity
  • 批准号:
    10188996
  • 项目类别:
  • 资助金额:
    $5.04万
  • 财政年份:
    2020
  • 负责人:
    David T Scadden
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: